These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26406407)

  • 41. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
    Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
    Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
    De Abreu FB; Pirolo LJ; Canevari Rde A; Rosa FE; Moraes Neto FA; Caldeira JR; Rainho CA; Rogatto SR
    Anticancer Res; 2007; 27(2):1199-205. PubMed ID: 17465263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive value of GGN and CAG repeat polymorphisms of androgen receptors in testicular cancer: a meta-analysis.
    Jiang W; Zhang J; Zhou Q; Liu S; Ni M; Zhu P; Wu Q; Li W; Zhang M; Xia X
    Oncotarget; 2016 Mar; 7(12):13754-64. PubMed ID: 26885616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CAG repeat polymorphism in the androgen receptor gene (AR) and its relationship to head and neck cancer.
    dos Santos ML; Sibov TT; Nishimoto IN; Kowalski LP; Miracca EC; Nagai MA
    Oral Oncol; 2004 Feb; 40(2):177-82. PubMed ID: 14693242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphic CAG Repeat and Protein Expression of Androgen Receptor Gene in Colorectal Cancer.
    Huang R; Wang G; Song Y; Wang F; Zhu B; Tang Q; Liu Z; Chen Y; Zhang Q; Muhammad S; Wang X
    Mol Cancer Ther; 2015 Apr; 14(4):1066-74. PubMed ID: 25637315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
    Liu YR; Jiang YZ; Yu KD; Shao ZM
    Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.
    Sasaki M; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2003 Jun; 305(4):1105-8. PubMed ID: 12767946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis.
    Hao Y; Montiel R; Li B; Huang E; Zeng L; Huang Y
    Breast Cancer Res Treat; 2010 Dec; 124(3):815-20. PubMed ID: 20431938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy.
    Asaga S; Kinoshita T; Hojo T; Suzuki J; Jimbo K; Tsuda H
    Clin Breast Cancer; 2013 Feb; 13(1):40-6. PubMed ID: 23103363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.
    Gottlieb B; Alvarado C; Wang C; Gharizadeh B; Babrzadeh F; Richards B; Batist G; Basik M; Beitel LK; Trifiro M
    Hum Mutat; 2013 Apr; 34(4):610-8. PubMed ID: 23377847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene.
    Dietzsch E; Laubscher R; Parker MI
    Int J Cancer; 2003 Oct; 107(1):38-45. PubMed ID: 12925954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer.
    Narita D; Anghel A; Cimpean AM; Izvernariu D; Cireap N; Ilina R; Ursoniu S
    Neoplasma; 2010; 57(3):198-206. PubMed ID: 20353269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
    Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.